Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06314971 · ClinicalTrials.gov registry record
Predicting Local and Distant Recurrence in T1 Colorectal Cancer
A clinical trial of Colorectal Cancer and Colorectal Neoplasms, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- 138
- Enrollment target
- 3
- Study locations
NCT06314971: Completed study of Colorectal Cancer and Colorectal Neoplasms, sponsored by City of Hope Medical Center.
NCT06314971 is a study of Colorectal Cancer and Colorectal Neoplasms that has completed, run by City of Hope Medical Center. The registered enrollment target is 138 participants, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (91% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06314971, a study of Colorectal Cancer and Colorectal Neoplasms, has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- 138 participants
- Enrollment target
- 3
- Study locations
Study Summary
Tumor recurrence significantly affects survival rates following the local resection of submucosal colorectal cancers (T1 CRC). Despite this, there are currently no reliable biomarkers established to predict recurrence in T1 CRC. This study seeks to improve the prediction of recurrence-free survival in individuals who have survived T1 CRC.
Primary Outcome
Time from curative-intent resection to the development of recurrence (or death)
Conditions Studied
Interventions
- OTHER Tw1CE
Study Locations (3)
Other
- Tokushima University - Tokushima
- Barcelona University - Barcelona
California
- City of Hope Medical Center - Duarte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2023-03-15 |
| Est. Completion | 2025-06-30 |
What the finished NCT06314971 record still lists
NCT06314971 is an observational study that tracks outcomes without assigning an intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (91% lower).
The record links to 6 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Tw1CE is the first listed.
NCT06314971 reports a single indexed study location in Other, California.
Frequently Asked Questions
What is clinical trial NCT06314971 about?
NCT06314971 is a clinical study titled "Predicting Local and Distant Recurrence in T1 Colorectal Cancer". Tumor recurrence significantly affects survival rates following the local resection of submucosal colorectal cancers (T1 CRC). Despite this, there are currently no reliable biomarkers established to predict recurrence in T1 CRC. This study seeks to improve the prediction of recurrence-free survival...
What is the current status of trial NCT06314971?
This trial is currently completed. The enrollment target is 138 participants. The study started on 2023-03-15. Estimated completion is 2025-06-30.
What conditions does trial NCT06314971 study?
This clinical trial studies the following conditions: Colorectal Cancer, Colorectal Neoplasms, Colorectal Adenocarcinoma, Colorectal Cancer Stage I, Colorectal Cancer Recurrent.
What interventions are being tested in trial NCT06314971?
The interventions under investigation include: Tw1CE (OTHER).
Who is sponsoring clinical trial NCT06314971?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06314971 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06314971's enrollment target sits among peer trials
138 180th of 381 higher than 200 of 381 other Colorectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04402788 · 138 participants · Phase 2
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- NCT04883255 · 138 participants · Early Phase 1
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
- NCT05620784 · 138 participants · Phase 3
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
- NCT05832086 · 138 participants · Phase 2
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI